JP2021532155A5 - - Google Patents

Info

Publication number
JP2021532155A5
JP2021532155A5 JP2021504826A JP2021504826A JP2021532155A5 JP 2021532155 A5 JP2021532155 A5 JP 2021532155A5 JP 2021504826 A JP2021504826 A JP 2021504826A JP 2021504826 A JP2021504826 A JP 2021504826A JP 2021532155 A5 JP2021532155 A5 JP 2021532155A5
Authority
JP
Japan
Prior art keywords
bladder
throspium
pharmaceutical composition
individual
composition according
Prior art date
Application number
JP2021504826A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021532155A (ja
JPWO2020028554A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/044478 external-priority patent/WO2020028554A1/en
Publication of JP2021532155A publication Critical patent/JP2021532155A/ja
Publication of JP2021532155A5 publication Critical patent/JP2021532155A5/ja
Publication of JPWO2020028554A5 publication Critical patent/JPWO2020028554A5/ja
Priority to JP2024121447A priority Critical patent/JP2024164020A/ja
Pending legal-status Critical Current

Links

JP2021504826A 2018-08-01 2019-07-31 トロスピウムを使用した過活動膀胱の治療方法 Pending JP2021532155A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024121447A JP2024164020A (ja) 2018-08-01 2024-07-26 トロスピウムを使用した過活動膀胱の治療方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862713414P 2018-08-01 2018-08-01
US62/713,414 2018-08-01
US201962850481P 2019-05-20 2019-05-20
US62/850,481 2019-05-20
PCT/US2019/044478 WO2020028554A1 (en) 2018-08-01 2019-07-31 Methods of treating overactive bladder using trospium

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024121447A Division JP2024164020A (ja) 2018-08-01 2024-07-26 トロスピウムを使用した過活動膀胱の治療方法

Publications (3)

Publication Number Publication Date
JP2021532155A JP2021532155A (ja) 2021-11-25
JP2021532155A5 true JP2021532155A5 (https=) 2022-08-10
JPWO2020028554A5 JPWO2020028554A5 (https=) 2022-08-10

Family

ID=69232612

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021504826A Pending JP2021532155A (ja) 2018-08-01 2019-07-31 トロスピウムを使用した過活動膀胱の治療方法
JP2024121447A Pending JP2024164020A (ja) 2018-08-01 2024-07-26 トロスピウムを使用した過活動膀胱の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024121447A Pending JP2024164020A (ja) 2018-08-01 2024-07-26 トロスピウムを使用した過活動膀胱の治療方法

Country Status (10)

Country Link
US (2) US11464734B2 (https=)
EP (1) EP3829582A4 (https=)
JP (2) JP2021532155A (https=)
KR (1) KR20210039403A (https=)
CN (1) CN112839653A (https=)
AU (1) AU2019315957A1 (https=)
BR (1) BR112021001337A2 (https=)
CA (1) CA3107461A1 (https=)
MX (1) MX2021001264A (https=)
WO (1) WO2020028554A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT4124339T (lt) 2014-03-06 2025-11-10 Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu
BR112020000832A2 (pt) 2017-07-25 2020-07-21 Taris Biomedical Llc métodos para tratar metástase tumoral
JOP20200124A1 (ar) 2017-11-08 2020-05-20 Taris Biomedical Llc طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك
CN112839653A (zh) 2018-08-01 2021-05-25 塔里斯生物医药公司 使用曲司氯铵治疗膀胱过度活动症的方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125696T3 (es) * 1996-11-27 1999-03-01 Pfleger R Chem Fab Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
US20060058777A1 (en) 2002-12-11 2006-03-16 Pia Norup Nielsen Urinary catheter device with a pharmaceutically active composition
WO2004064789A2 (en) 2003-01-16 2004-08-05 University Of Rochester Quaternary antimuscarinic compounds for the treatment of bladder diseases
EP1703895A2 (en) * 2004-01-13 2006-09-27 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
ES2322148T3 (es) 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060128808A1 (en) 2004-10-20 2006-06-15 Galderma Research & Development, S.N.C. Method of using adapalene in acne maintenance therapy
WO2006101954A2 (en) * 2005-03-17 2006-09-28 Indevus Pharmaceuticals, Inc. Interstitial cystitis treatment
US7390816B2 (en) * 2005-06-21 2008-06-24 Bridge Pharma, Inc. Methods for treating urinary incontinence in patients suffering from memory disorders
DK1933810T3 (da) 2005-08-11 2013-01-28 Childrens Medical Center Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
ES2365161T3 (es) 2005-09-02 2011-09-23 Theravida, Inc. Terapia para el tratamiento de la vejiga hiperactiva.
EP1967202A1 (en) 2007-03-05 2008-09-10 AEterna Zentaris GmbH Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity
KR101538748B1 (ko) 2007-12-11 2015-07-22 메사추세츠 인스티튜트 오브 테크놀로지 이식형 의약 투여 장치와 방광과 기타 신체 낭 또는 내강의 치료 방법
EA201170297A1 (ru) 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
DK2445570T3 (da) 2009-06-26 2013-02-25 Taris Biomedical Inc Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
PL3884988T3 (pl) 2009-12-17 2025-09-08 Taris Biomedical Llc Urządzenie implantowalne z tolerancją wewnątrzpęcherzową
EP3795121A1 (en) 2010-08-05 2021-03-24 TARIS Biomedical LLC Ureteral stent drug delivery device
WO2012048114A1 (en) 2010-10-06 2012-04-12 Taris Biomedical, Inc. Time-selective bioresorbable or collapsible drug delivery systems and methods
JP2014503554A (ja) 2011-01-10 2014-02-13 タリス バイオメディカル,インコーポレイテッド 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン
EP2670398B1 (en) 2011-02-04 2017-06-07 TARIS Biomedical LLC Implantable device for controlled release of low solubility drug
MX367070B (es) 2012-08-31 2019-08-05 Taris Biomedical Llc Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata.
SG11201501424SA (en) 2012-08-31 2015-03-30 Taris Biomedical Llc Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin
MX379066B (es) * 2012-09-18 2025-03-04 Taris Biomedical Llc Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior.
EP2719374A1 (en) * 2012-10-12 2014-04-16 Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Drug delivery device
JP2016508842A (ja) 2013-03-05 2016-03-24 タリス バイオメディカル エルエルシー 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法
EP2968120B1 (en) 2013-03-15 2026-01-14 TARIS Biomedical LLC Drug delivery devices and methods for drug delivery
KR102557326B1 (ko) 2013-03-15 2023-07-19 타리스 바이오메디컬 엘엘씨 약물-투과성 구성요소를 가지는 약물 전달 장치
KR102385603B1 (ko) 2013-08-19 2022-04-11 타리스 바이오메디컬 엘엘씨 다중 유닛 약물 전달 장치 및 방법
EP3065807A1 (en) 2013-11-05 2016-09-14 TARIS Biomedical LLC Osmotic drug delivery devices, kits, and methods
LT4124339T (lt) 2014-03-06 2025-11-10 Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu
KR20220061253A (ko) 2014-06-26 2022-05-12 타리스 바이오메디컬 엘엘씨 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
WO2016172704A1 (en) 2015-04-23 2016-10-27 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
US20190060407A1 (en) * 2015-09-10 2019-02-28 Assistance Publique - Hôpitaux De Paris Use of interleukin 2 for treating spondyloarthritis
JP6283440B1 (ja) * 2016-10-27 2018-02-21 Eaファーマ株式会社 逆流性食道炎の再発抑制剤
PT3432970T (pt) * 2017-02-01 2021-05-26 Taris Biomedical Llc Dispositivos de administração de fármaco in vivo
BR112020000832A2 (pt) 2017-07-25 2020-07-21 Taris Biomedical Llc métodos para tratar metástase tumoral
CN112839653A (zh) 2018-08-01 2021-05-25 塔里斯生物医药公司 使用曲司氯铵治疗膀胱过度活动症的方法

Similar Documents

Publication Publication Date Title
JP2021532155A5 (https=)
Munro et al. Maintenance treatment with cyclosporin in atopic eczema
Arshinof et al. Use of topical nonsteroidal anti-inflammatory drugs in excimer laser photorefractive keratectomy
WO2021126320A9 (en) Treatment of amyotrophic lateral sclerosis and related disorders
US20160317468A1 (en) Uses of cannabidiol for treatment of infantile spasms
Berth‐Jones et al. Benign familial chronic pemphigus (Hailey‐Hailey disease) responds to cyclosporin
AU2018337933A1 (en) Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults
IL315023A (en) Neuroactive steroids for treatment of cns-related disorders
US20220098291A1 (en) Treatment of Parkinson's Disease
JP2024056908A (ja) デュラグルチドを使用する方法およびデュラグルチドを含有する組成物
MX2024010637A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
KR20070011276A (ko) 쿠에티아핀 항정신병제를 사용한 정신병의 치료
US11351229B2 (en) Combination therapies for treating infantile spasms and other treatment resistant epilepsies
CA2506481A1 (en) Method of treatment of conditions by administration of streptolysin o
JPWO2020028554A5 (https=)
XUAN et al. Efficacy of oxymetazoline eye drops in non-infectious conjunctivitis, the most common cause of acute red eyes
CN1290166A (zh) 运动障碍的治疗
KR20170118830A (ko) 조현병의 치료를 위한 일로페리돈
EP3167881B1 (en) Locally administered ethamsylate as a medicament
TW200418447A (en) New method for treating urinary disorders
WO2006130769A3 (en) Methods for treatment of growth disorders
KR20170040808A (ko) 다한증을 치료하는 방법
RU2021104894A (ru) Способы лечения гиперактивного мочевого пузыря с применением троспия хлорида
CN120284871B (zh) 用于鼻腔的含奥洛他定与溴莫尼定的复方制剂组合物及其制备方法
EP4205738A1 (en) Application of sesquiterpene lactone in preparing drug for treating optic neuritis